Because inflammation may play an important role in progression of Alzheimer’s disease, and CCR2 and CCR5 have a primary function in recruitment of leukocytes to inflammatory sites, we hypothesized that these variations might influence the risk of developing AD in our population. This evidence concerns the gene CCR5 and Alzheimer disease.